ReviR Therapeutics
Brisbane
About ReviR Therapeutics
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs. Its RNA therapeutics treat cancer, rare genetic disorders, and infectious diseases. It also develops an AI-based and computation-empowered platform to discover RNA-targeting therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $54.6M
- Funding stage: Early Stage Venture
- Last round: Grant (Jan 2025)
- Website: revirtx.com
Industries & Categories
Alternative Medicine, Artificial Intelligence (AI), Biotechnology, Genetics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/revir-therapeutics-62514 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.